Certara Inc (NASDAQ:CERT) — Market Cap & Net Worth
Market Cap & Net Worth: Certara Inc (CERT)
Certara Inc (NASDAQ:CERT) has a market capitalization of $1.12 Billion ($1.12 Billion) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #8368 globally and #2442 in its home market, demonstrating a 5.79% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Certara Inc's stock price $8.40 by its total outstanding shares 159139562 (159.14 Million). Also see total assets of Certara Inc for a full breakdown of the balance sheet.
Certara Inc Market Cap History: 2020 to 2026
Certara Inc's market capitalization history from 2020 to 2026. Data shows change from $5.37 Billion to $1.34 Billion (-23.06% CAGR). Also see cash efficiency ratio of Certara Inc for how efficiently the company converts equity into cash flow.
Index Memberships
Certara Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.04% | #243 of 976 |
|
NASDAQ Composite
IXIC
|
$41.74 Trillion | 0.00% | #908 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.10% | #447 of 602 |
Weight: Certara Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Certara Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Certara Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Certara Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.35x
Certara Inc's market cap is 3.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $5.37 Billion | $243.53 Million | -$49.40 Million | 22.04x | N/A |
| 2021 | $4.52 Billion | $286.10 Million | -$13.27 Million | 15.81x | N/A |
| 2022 | $2.56 Billion | $335.64 Million | $14.73 Million | 7.62x | 173.60x |
| 2023 | $2.80 Billion | $354.34 Million | -$55.36 Million | 7.90x | N/A |
| 2024 | $1.69 Billion | $385.15 Million | -$12.05 Million | 4.40x | N/A |
| 2025 | $1.40 Billion | $418.84 Million | -$1.59 Million | 3.35x | N/A |
Competitor Companies of CERT by Market Capitalization
Companies near Certara Inc in the global market cap rankings as of September 17, 2026. Review Certara Inc tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Certara Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
Certara Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Certara Inc's market cap moved from $5.37 Billion to $ 1.34 Billion, with a yearly change of -23.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.34 Billion | -4.65% |
| 2025 | $1.40 Billion | -17.28% |
| 2024 | $1.69 Billion | -39.45% |
| 2023 | $2.80 Billion | +9.46% |
| 2022 | $2.56 Billion | -43.46% |
| 2021 | $4.52 Billion | -15.72% |
| 2020 | $5.37 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Certara Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.12 Billion USD |
| MoneyControl | $1.12 Billion USD |
| MarketWatch | $1.12 Billion USD |
| marketcap.company | $1.12 Billion USD |
| Reuters | $1.12 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Certara Inc
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pha… Read more